Genetic and Epigenetic Regulators of Pluripotency  by Surani, M. Azim et al.
Leading Edge
ReviewGenetic and Epigenetic
Regulators of Pluripotency
M. Azim Surani,1,* Katsuhiko Hayashi,1 and Petra Hajkova1
1Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK
*Correspondence: as10021@mole.bio.cam.ac.uk
DOI 10.1016/j.cell.2007.02.010
Genetic and epigenetic mechanisms regulate the transition from the totipotent zygote to
pluripotent primitive ectoderm cells in the inner cell mass of mouse blastocysts. These
pluripotent cells can be propagated indefinitely in vitro, underpinned by a unique epigenetic
state. Following implantation of the blastocyst, diverse epigenetic modifiers control dif-
ferentiation of pluripotent epiblast cells into somatic cells, while specification of germ cells
requires repression of the somatic program. Regenerating totipotency during development
of germ cells entails re-expression of pluripotency-specific genes and extensive erasure of
epigenetic modifications. Increasing knowledge of key underlying mechanisms heightens
prospects for creating pluripotent cells directly from adult somatic cells.Development and cell fate determination require close
coordination between genetic and epigenetic programs.
These are in turn regulated by signaling molecules, which
together with interactions among neighboring cells induce
appropriate transcriptional and epigenetic responses that
are essential for cell fate determination. In addition, epige-
netic mechanisms contribute to the repression of inappro-
priate developmental programs in time and space while
ensuring heritability of existing or newly acquired pheno-
typic states. These extrinsic and intrinsic regulators deter-
mine the developmental origin and subsequent propaga-
tion of pluripotent states in vivo and in vitro.
Totipotency and pluripotency are two quite distinct epi-
genetic states with different developmental potentials.
The zygote and to some extent early blastomeres are toti-
potent, as they are self-contained entities that can give
rise to the whole organism. As these cells undergo cleav-
age divisions, they lack the capacity for self-renewal. Plu-
ripotent cells are established from totipotent blastomeres
within the inner cell mass (ICM) of blastocysts. As these
cells cease cleavage divisions and acquire properties of
normal cell division, they become responsive to external
signals and acquire the capacity for self-renewal when
cultured in vitro. Germ cells, while highly specialized, are
unique because the end product of the lineage is the toti-
potent zygote. Furthermore, early germ cells repress the
somatic program, and their epigenetic and transcriptional
statuses share features that are compatible with pluripo-
tency, although they cannot differentiate into diverse cell
types. However, pluripotent stem cells can be derived
in vitro from both the ICM and germ cells. Here we discuss
the relationship between all of these different develop-
mental states and their in vitro derivatives. We confine
our discussion to chromatin- and DNA-based epigenetic
changes and the transcription factors that contribute to
their inherent states.Pluripotent Cell Lineages and Their Derivatives
When development commences, the totipotent zygote
contains key maternally inherited transcriptional and
epigenetic factors that regulate early development. The
switch from the zygotic to embryonic program occurs
when transcription starts at the late zygote and at the
two-cell stage (Solter et al., 2004). This is followed by pre-
implantation development involving about six cleavage
divisions to form a blastocyst (Chazaud et al., 2006;
Niwa et al., 2005; Yamanaka et al., 2006), a unique devel-
opmental stage in mammals without parallel in other
organisms. Blastocysts consist of approximately 60 cells,
with an ICM containing the pluripotent primitive ectoderm
(PEct) cells, and the specialized outer trophectoderm cells
that are required for implantation and development of the
placenta. The ICM is the foundation of all somatic tissues
and germ cells in adults. Following implantation, the ICM
commences development to form the epiblast cells of
the early egg cylinder, which are also pluripotent as
judged by the expression of pluripotent cell-specific
genes such as Oct4. These cells respond to signals from
the surrounding extraembryonic tissues that direct differ-
entiation and initiation of gastrulation (see Figure 1).
One of the earliest developmental events at the onset of
gastrulation is the establishment of the founder germ cells
(Surani et al., 2004). Germ cells are highly specialized cells
established by a specific transcriptional program that
includes repression of the somatic fate. Importantly, this
is the only lineage that exhibits expression of pluri-
potency-specific genes after gastrulation. The transcrip-
tional program involved in generating germ cells must
also regulate the extensive epigenetic reprogramming of
the genome, including genome-wide erasure of existing
epigenetic modifications, which is evidently unique to
this lineage and an essential step toward the eventual
totipotent state.Cell 128, 747–762, February 23, 2007 ª2007 Elsevier Inc. 747
Figure 1. Genetic and Epigenetic Regu-
lation of Pluripotency during Mouse
Development
The totipotent zygote contains maternally in-
herited epigenetic modifiers and transcription
factors, including Oct4, Sox2, and Ezh2.
These, together with the embryonic transcripts,
regulate development to the blastocyst stage,
where the pluripotent cells are established in
the inner cell mass (ICM). Deletion of Oct4
and nanog compromises development of the
ICM (Chambers et al., 2003; Mitsui et al.,
2003; Nichols et al., 1998). In the postimplan-
tation embryo, pluripotent epiblast cells are
controlled by diverse repressive mechanisms
during their differentiation into somatic and
germ cell lineages (the latter of which undergo
specification following repression of the so-
matic program). The early germ cells exhibit
epigenetic and transcriptional states that are
associated with pluripotency, and the ensuing
epigenetic reprogramming within this lineage
re-generates totipotency. The figure depicts
the main epigenetic changes occurring during
critical stages of development.The ICM and primordial germ cells (PGCs) are in turn the
precursors of pluripotent embryonic stem (ES) and embry-
onic germ (EG) cells, respectively, which are derived and
maintained only in culture in vitro (Durcova-Hills et al.,
2006; Matsui et al., 1992; Resnick et al., 1992; Ying
et al., 2003). More recently, pluripotent stem cells have
been derived from spermatogonial stem cells (Kanatsu-
Shinohara et al., 2005). This suggests that the transcrip-
tional network and epigenetic regulators capable of sup-
porting pluripotency may be maintained during germ cell
development. The ES cells can exhibit a perpetual plurip-
otent state in vitro, which may correspond to but is not
identical to the transient pluripotent state of PEct cells
in vivo. For example, specific cytokines promote the
derivation and maintenance of ES cells. Leukemia inhibi-
tory factor (LIF) and BMP4 are key factors that may not
only modify PEct and evoke appropriate responses during
the derivation of ES cells but also sustain pluripotency
indefinitely in culture (Ying et al., 2003; Chambers and
Smith, 2004). When released from the influence of these
cytokines in vitro or following their introduction back into
the blastocyst, ES cells undergo differentiation, just like
PEct cells. These observations stress the transient nature
of the pluripotency of PEct cells, as they progress quickly
to the next developmental stage in vivo but can be main-
tained indefinitely as ES cells in vitro. Because ES (and EG)
cells have no strict equivalents in vivo, theirs is a unique
epigenetic state (Figure 1).748 Cell 128, 747–762, February 23, 2007 ª2007 Elsevier IncFrom Totipotency to Pluripotency
First, we consider the critical events that occur within the
totipotent zygote and the origin of pluripotent cells during
early development.
The Zygote: Creating a Template for Transcription
At fertilization, when the parental genomes come together
in the oocyte cytoplasm to form the totipotent zygote, the
paternal genome has a very different developmental his-
tory from the resident maternal genome and must acquire
an appropriate epigenetic state to participate in develop-
ment (Arney et al., 2001). Initially, the paternal genome
is highly condensed, partly through its binding by prot-
amines, which are rapidly replaced by histones. As this re-
placement occurs prior to S phase, a particular histone
variant, H3.3, is selectively incorporated, probably by
the histone chaperone Hira, into the paternal genome
(Torres-Padilla et al., 2006; van der Heijden et al., 2005).
Interestingly, the canonical histone H3.1 is absent from
the paternal pronucleus before DNA replication (van der
Heijden et al., 2005). This initial epigenetic asymmetry
between the parental genomes is further manifested by
differences in histone modifications and localization of
numerous epigenetic modifiers such as Ezh2 (Erhardt
et al., 2003).
The paternal pronucleus also features a specific pattern
of histone modifications. While H3K4me1, H3K9me1, and
H3K27me1 are detected at fertilization, H3K4me3,
H3K9me2, and H3K27me3 become detectable only after.
DNA replication (although H3K9me2 is detected very
weakly) (Arney et al., 2001; Lepikhov and Walter, 2004;
Santos et al., 2005; see also the Review by A. Groth
et al., page 721 of this issue). The epigenetic status of
the paternal pronucleus changes in other respects as
well. There is extensive and rapid genome-wide DNA de-
methylation of the paternal genome (Mayer et al., 2000;
Oswald et al., 2000). The molecular mechanism of this
global DNA demethylation is currently unknown, but cor-
rect epigenetic configuration of the paternal chromatin is
likely to be important given the fact that the maternal
genome escapes this process. As histone methylation
can direct DNA methylation, at least in particular genomic
regions, the differences in histone modifications between
parental pronucleimay explain the protection of themater-
nal genome from undergoing DNA demethylation. More
recently, Stella was shown to be required for preventing
DNA demethylation of the maternal genome; in Stella-
deficient oocytes, the maternal genome is massively
demethylated (Nakamura et al., 2007). However, as Stella
is found in bothmaternal andpaternal pronuclei, additional
factors must cooperate to protect the maternal genome
from DNA demethylation.
Switching from the Totipotent Zygote
to the Embryonic Program
The zygote contains a number of key maternally inherited
transcription factors, including some that are essential for
pluripotency, such as Oct3/4 and Sox2, as well as epige-
netic factors for histonemodifications including Polycomb
group (PcG) proteins such as Ezh2 and Eed, proteins of
histone metabolism (Padi4), and chromatin remodelers
such as Brg1 (see the Review by B. Schuettengruber
et al., page 735 of this issue). As the key requirement at
this stage of development is to convert the quiescent ge-
nome into a transcriptionally competent one, this must be
accomplished by maternally inherited factors in the oo-
cyte. Among the maternal factors whose function has
been well defined is Brg1, a component of the SWI/SNF
chromatin-remodeling complex (Bultman et al., 2006).
Loss of Brg1 results in reduced transcription and arrest
at the two-cell stage. Another example is Npm2, whose
presence in the oocyte is essential for histone deacetyla-
tion and heterochromatin formation surrounding the
nucleoli (Burns et al., 2003; Table 1).
From the late zygote to the two-cell stage, when the em-
bryonic genome becomes activated, the epigenetic status
of theparental genomesstarts to become lessdistinct,with
theexceptionofDNAmethylation.Theoverall differences in
DNA methylation persist for one to two cleavage divisions,
followed by a passive and steady decline through preim-
plantation development (Mayer et al., 2000). This change
is accompanied by a gradual increase in H3K9me2 (Santos
et al., 2003; Yeo et al., 2005). Notably, examination of
cloned mammalian embryos has revealed that the levels
ofmethylatedH3K9 inpreimplantation embryosare impor-
tant for further development (Santos et al., 2003). This pro-
vides further evidence for the importance of the chromatin
configuration during this developmental stage.The Origin of Pluripotent Cells
The early blastomeres, until about the eight-cell stage, are
essentially identical and totipotent and retain considerable
plasticity. However, individual blastomeres at the four-cell
stage may have some bias in their contribution to the ICM
and trophectoderm lineages in an unperturbed embryo
(Zernicka-Goetz, 2005).Although thedescendentsofasin-
gle eight-cell-stage blastomere may give rise only to tro-
phectoderm cells, no descendents of a single blastomere
at this stage can give rise only to pluripotent PEct cells. At
the eight-cell stage, each blastomere becomes polarized
and divides either symmetrically to generate two polar
outer cells (OCs) or asymmetrically to generate an apolar
inner cell (IC) and a polar OC. Thus, between the eight-
and 16-cell stage, the first distinct group of ICs and OCs
are generated, which are the precursors of the pluripotent
PEct cells in the ICM and the trophectoderm cells, respec-
tively (Johnson and Ziomek, 1981; Yamanaka et al., 2006).
The ‘‘permissive’’ epigenetic state generated in the
zygote allows a number of key transcription factors to
play a critical role during development of the blastocyst.
Among these factors areOct4 andCdx2, which are essen-
tial for development of the ICM and trophectoderm, re-
spectively (Niwa et al., 2005). In the early morula stage,
both of these factors are expressed in all blastomeres. In
the late morula stage, when the IC and OC are formed,
Oct4 is detected in the IC whereas Cdx2 is confined to
the OC (Niwa et al., 2005). The ICM itself comprises the
inner PEct and the outer primitive endoderm (PEnd). An
additional feature of the ICs in a morula is the expression
of Nanog, a homeodomain protein (Chambers et al., 2003;
Mitsui et al., 2003). Recent studies show that the expres-
sion of nanog in early blastomeres may be regulated by
the histone arginine methyltransferase Carm1 (Torres-
Padilla et al., 2007), although the expression of Carm1
does not commit the cell to develop exclusively as an
IC. The role of Nanog is apparently to promote develop-
ment of PEct, as the ICM of the E3.5 blastocyst shows
a mutually exclusive mosaic pattern of expression of
Nanog and Gata6 in individual cells. (Expression of the lat-
ter is essential for the development of PEnd cells.) If Gata6
expression is eliminated from the ICM, all of the cells show
expression of Nanog (Chazaud et al., 2006).
No distinct epigenetic differences between ICs andOCs
in the morula have been reported, but we cannot exclude
a possibility that such differences could dictate mutually
exclusive expression of the key transcription factors de-
scribed above. In any event, the ICs at the 16-cell stage
are not yet fully committed and can develop into trophec-
toderm cells if extracted and exposed to the outside envi-
ronment during subsequent development. It is likely, how-
ever, that once distinct cell fate decisions are made,
appropriate gene- or locus-specific epigenetic modifica-
tions may ensure that the identities of the pluripotent PEct
cells, aswell as those of the trophectoderm andPEnd cells
in the blastocyst, are maintained. The PEct cells in partic-
ular may be constrained from undergoing differentiation
into extraembryonic tissues by epigenetic regulators.Cell 128, 747–762, February 23, 2007 ª2007 Elsevier Inc. 749
Table 1. Epigenetic Modifiers that Are Critical for Pre- and Early Postimplantation Development in the Mouse
Modifier Function Mutant Phenotype
Maternally
Inherited
ES Cell
Derivation Reference
Histone Modifications
Glp/Ehmt1 HMTase Severe growth retardation and lethality at E9.5;
reduction of H3K9me1 and H3K9me2 in embryos
ND yes Tachibana
et al. (2005)
G9a/Ehmt2 HMTase Loss of H3K9 methylation in euchromatin;
developmental and growth arrest at E8.5
yes yes Tachibana
et al. (2002)
Eset/
SETDB1
HMTase Peri-implantation lethality (between E3.5 and E5.5);
defects in ICM outgrowth
yes no Dodge
et al. (2004)
Suv39h1
Suv39h2
HMTase Double knockout shows loss of H3K9 methylation
in heterochromatin; polyploidy in MEF cells;
chromosome pairing defects during
spermatogenesis; male sterility and death of some
double-mutant embryos at E14.5
ND yes Peters
et al. (2001)
Ezh2/
Enx-1
HMTase
PRC2
complex
Growth defect of the primitive ectoderm;
peri-implantation lethality
yes no O’Carroll
et al. (2001)
Mll/All-1 HMTase Skeletal abnormalities; Hox gene misregulation
(loss of H3K4me1 and aberrant DNA methylation);
other morphogenetic defects by E10.5; embryonic
lethality; truncation in exon 5 leads to early
developmental arrest prior to two-cell stage
ND ES viable
(defective
gene
expression)
Glaser
et al. (2006);
Yagi et al.
(1998); Yu
et al. (1995)
Meisetz HMTase Meiotic defect causing sterility no ND Hayashi
et al. (2005)
PRMT1 Arg MTase Early postimplantation lethality before gastrulation ND yes Pawlak
et al. (2000)
Blimp1/
PRDM1
PR/SET
domain
protein
Patterning defects; loss of germ cell precursors no yes Ohinata
et al. (2005);
Vincent
et al. (2005)
Gcn5 HAT Lethal at E7.5–E8.5; patterning defects yes ND Xu et al.
(2000)
HDAC1 HDAC Defects in proliferation; delayed development;
embryonic lethality by E10.5
yes yes (ES
cells
defective)
Lagger
et al. (2002)
Polycomb
Eed PRC2/3
complex
Defective gastrulation; failure to maintain
inactive X in trophoblast cells
yes yes Shumacher
et al. (1996)
Suz12 PRC2/3
complex
Early postimplantation lethality; gastrulation
defects
yes ND Pasini
et al. (2004)
YY1 PRC2/3
interaction
Defects in epiblast cell growth/survival;
peri-implantation lethality
yes no Donohoe
et al. (1999)
Ring1b/
Rnf2
Ubiquitin
ligase PRC1
complex
Gastrulation defects; lethality by E9.5 yes ES
viable
Voncken
et al. (2003)
DNA Methylation
Dnmt1 DNA MTase Genome-wide demethylation; developmental
arrest at E8.5
yes yes Li et al.
(1992)
Dnmt3a DNA MTase Malfunction of gut; spermatogenesis defects;
postnatal lethality (4 weeks of age)
yes yes Okano
et al. (1999)
Dnmt3b DNA MTase Demethylation of minor satellite DNA; mild neural
tube defects; embryonic lethality at E14.5–E18.5
yes yes Okano
et al. (1999)750 Cell 128, 747–762, February 23, 2007 ª2007 Elsevier Inc.
Table 1. Continued
Modifier Function Mutant Phenotype
Maternally
Inherited
ES Cell
Derivation Reference
Dnmt3L DNA MTase
(no enzymatic
function)
Failure to establish maternal methylation
imprints in oocytes; male sterility due to
spermatogenesis defects
yes ND Bourc’his et al.
(2001); Hata
et al. (2002)
MBD Proteins
Mbd3 Chromatin-
remodeling
NuRD complex
Normal implantation; developmental arrest
at E6.5 or earlier
yes no (ES
viable)
Hendrich et al.
(2001); Kaji
et al. (2006)
Chromatin-Remodeling/Histone Chaperones
Brg1 SWI/SNF Growth defects of primitive ectoderm and
trophectoderm; peri-implantation lethality;
oocyte depletion causes zygotic arrest
yes no Bultman et al.
(2000); Bultman
et al. (2006)
Snf5/Ini1/
Smarcb1
SWI/SNF Peri-implantation lethality ND no Klochendler-
Yeivin et al.
(2000)
Lsh/Hells/
PASG
SWI/SNF Global demethylation of genomic DNA at E13.5;
role in meiotic chromosome synapsis and
retrotransposon silencing in female germline;
postnatal lethality
yes ND Geiman and
Muegge
(2000); Sun
et al. (2004);
De La Fuente
et al., 2006
Srg3/
Smarcc1
SWI/SNF Lethality around implantation; defective
ICM outgrowth
ND no Kim et al.
(2001)
ATRX SWI/SNF Male-specific embryonic lethality by E9.5 due
to defect in formation of extraembryonic
trophoblast and X inactivation
yes ND Garrick
et al. (2006)
CAF-1 Histone
chaperone
Early preimplantation lethality; arrest at 16-cell
stage; defects in constitutive heterochromatin
yes no Houlard
et al. (2006)
HIRA Histone
chaperone
Gastrulation defects; embryonic lethality
by E10.5
yes yes Roberts
et al. (2002)
Nasp Histone
chaperone
Preimplantation lethality at blastocyst stage yes no Richardson
et al. (2006)
Npm2 Histone
chaperone
Defective nucleolar structure; loss of
heterochromatin and acetylated histone H3;
early preimplantation lethality (most embryos
arrested at two-cell stage)
yes no Burns et al.
(2003)
miRNA Metabolism
Ago2 miRNA
processing
Lethal at E9.5 ND ND Liu et al.
(2004)
Dicer miRNA
processing
Postimplantation lethality before gastrulation yes no (ES
viable)
Bernstein
et al. (2003)
The role of key epigenetic modifiers has been established by genetic experiments. Deletion of many of these genes also causes
a failure of the ICM to give rise to ES cells in vitro, suggesting a direct role for these factors in the establishment or maintenance
of pluripotency. ND, not determined; E, embryonic day; MBD, methylcytosine binding domain; HAT, histone acetyltransferase;
HMTase, histone methyltransferase; DNA MTase, DNA methyltransferase; ES viable, viability of ES cells when the second allele
or both alleles are deleted from established ES cells in vitro.Nevertheless, at the blastocyst stage, there are clear
epigenetic differences between the ICM and trophecto-
derm cells. This is evident from the analysis of X inacti-
vation in these tissues, which may be indicative of other
differences between them. In female embryos, the ‘‘im-printed’’ paternal X chromosome is preferentially inacti-
vated during preimplantation development. The initial
event involves expression of the noncoding RNA Xist
from the paternal X chromosome, which is followed by
histone modifications including loss of H3K4me2 andCell 128, 747–762, February 23, 2007 ª2007 Elsevier Inc. 751
Figure 2. The Transition from Totipo-
tency to Pluripotency
The zygote contains maternally inherited
factors that, together with the embryonic
transcripts, regulate cleavage divisions. At the
morula stage, two distinct cell populations, in-
ner cells (ICs) and outer cells (OCs), are formed.
The ICs are the precursors of the pluripotent
primitive ectoderm cells (PEct) within the ICM.
The ICM also contains the outer layer of primi-
tive endoderm cells (PEnd). Cleavage divisions
are replaced by cell divisions as the primitive
ectoderm cells within the ICM undergo final
epigenetic reprogramming to generate pluri-
potent cells. These cells can be propagated
indefinitely under appropriate conditions as
pluripotent ES cells in vitro, where they exhibit
a unique epigenetic state, and can differentiate
into all of the diverse cell types upon reintro-
duction into host blastocysts.H3K4me3 and the gain of H3K9me2 and H3K27me3, as
well as the ubiquitination of H2A (Heard, 2004; see also
the Review by P.K. Yang and K.I. Kuroda, page 777 of
this issue). Notably, all of the cells of blastocysts initially
show epigenetic marks that are consistent with the inacti-
vated paternal X chromosome. In the late blastocyst, how-
ever, the epigenetic marks associated with the inactive
paternal X chromosome are preferentially erased in the
PEct cells, where both X chromosomes become poten-
tially active (Mak et al., 2004; Okamoto et al., 2004). The
paternal X chromosome stays imprinted and inactivated
only in the extraembryonic trophectoderm and PEnd cells.
The erasure of the imprint on the paternal X chromosome
occurs in the ICM, where the pluripotent PEct cells reside,
and this event may signify the establishment of the plurip-
otent state. Subsequently, there is random X inactivation
in the developing embryo when PEct cells commence dif-
ferentiation (Figure 2).
Profound epigenetic differences between the ICM and
trophectoderm cells appear not only at the level of histone
modifications but also at the level of DNAmethylation. Fol-
lowing passive DNA demethylation, which is characteris-
tic for preimplantation development, the ICM of the blas-
tocyst starts to reacquire DNA methylation marks, which
is coupled with the restricted expression of Dnmt3b in
the ICM (Watanabe et al., 2002). By contrast, trophecto-
derm cells stay relatively hypomethylated. These differ-
ences are also reflected in the mechanisms used for the
maintenance of genomic imprints, which involves modifi-
cations of histones and DNA methylation in the placenta
and the embryo, respectively (Lewis et al., 2004). This is
perhaps an evolutionary adaptation, given that the pla-
centa exists for a relatively short duration compared to
the embryo, which develops into an adult.
The ICM ‘‘Niche’’ and Establishing
the Pluripotent State
Significant epigenetic events such as the erasure of the
epigenetic marks associated with the paternal inactive
X chromosome occur specifically in PEct cells within the752 Cell 128, 747–762, February 23, 2007 ª2007 Elsevier Inc.ICM, which may be indicative of other epigenetic reprog-
ramming events. It is possible that X reactivation observed
in the PEct cells is a consequence of epigenetic reprog-
ramming, which may be essential in these cells for them
to acquire pluripotency. Currently, little is known about
the precise mechanisms that trigger these epigenetic
changes in PEct cells and what other epigenetic changes
occur in these cells that could be critical for pluripotency.
It is possible that the ICM provides a ‘‘niche’’ where sig-
naling molecules from the surrounding cells may regulate
the erasure of some of the epigenetic modifications as
PEct cells acquire pluripotency. The reactivation of the in-
active paternal X chromosome includes uplifting of chro-
matin marks, such as H3K27me3, which is introduced
by Ezh2, a member of the PcG complex (Mak et al.,
2004; Okamoto et al., 2004). It is possible that the under-
lying mechanism could have some similarities with the
molecular processes that are associated with the transde-
termination phenomenon in Drosophila. In the imaginal
discs, signaling molecules drive the transdetermination
process that involves uplifting of the repression of the ex-
isting phenotypic identity exerted by the PcGproteins (Lee
et al., 2005; Maurange et al., 2006). This results in in-
creased developmental plasticity and establishment of
a new cellular identity. If such a model applies in the
case of ICM, we may envisage that certain signaling mol-
ecules may trigger epigenetic reprogramming of PEct
cells, including erasure of paternal X inactivation during
the establishment of pluripotency in PEct cells. Reprog-
ramming in the ICM may then include general disruption
of heterochromatic gene silencing, leading to an in-
creased genomic plasticity. Importantly, these reprog-
ramming processes occur in the presence of transcription
factors such as Nanog that are expressed specifically in
the ICM (Chambers et al., 2003; Mitsui et al., 2003), which
are necessary for the acquisition and the maintenance of
pluripotency. While PEct cells undergo epigenetic
changes associated with pluripotency, there are also im-
portant changes in the nature of the cell cycle and division.
Notably, cleavage divisions that accompany early
development and result in progressive reduction in cell
size are replaced by normal cell divisions accompanied
by cell growth.
The Zygote and ICM—Two Distinct
Epigenetic Entities
Further insights into the epigenetic mechanisms that
regulate pluripotency come from examining the fate of
somatic nuclei in cloning experiments, which may be in-
formative regarding how the ICM niche may play a role
in conferring pluripotency. Experiments have demon-
strated that when a female (XX) somatic nucleus is trans-
planted into the oocyte, the original inactive X (Xi) is pref-
erentially inactivated in the extraembryonic tissues (Bao
et al., 2005; Eggan et al., 2000). However, as is the case
for the imprinted paternal X chromosome in normal em-
bryos, this persisting epigenetic memory associated with
the Xi is erased in the ICM, which is followed by random
X inactivation during subsequent development. This anal-
ysis also suggests that the oocyte may have some poten-
tial for DNA demethylation but that the histone modifica-
tion mark, H3K27me3, which is imposed by the PcG
protein Ezh2 on the Xi, cannot be erased in the zygote
and during early preimplantation development. This
mark is only erased later in the ICM, thus leading to sub-
sequent random X chromosome inactivation in the em-
bryo (Bao et al., 2005; Eggan et al., 2000). These studies
emphasize the fact that the oocyte and the ICM have
distinct potentials for modifying epigenetic information,
and the specific features of the ICM may be critical for
the generation of pluripotent cells in the ICM.
The impression from at least some studies involving
nuclear transplantation using somatic cells as donors is
that the development of the trophectoderm in blastocysts
is relatively less affected compared to the ICM (Kishigami
et al., 2006). This can be judged by the highly variable ex-
pression of many markers of pluripotency, such as Oct4
(Bortvin et al., 2003), whereas the expression of Cdx2 in
the trophectoderm is relatively stable. By contrast, devel-
opment following transplantation of nuclei from ES cells is
significantly better. One possibility is that the ES cell chro-
matin is more responsive to the maternally inherited tran-
scription (and epigenetic) factors present in the oocyte.
Gene silencing in ES cells is governed by an unusual com-
bination of histone modifications on individual loci, which
include the repressive H3K27me3 that coexists with the
H3K4 modification usually associated with active genes.
Similar epigenetic marks are also detected on the mater-
nal pronuclei (Erhardt et al., 2003; Lepikhov and Walter,
2004; Santos et al., 2005). By contrast, the H3K9me2 re-
pressive mark and the exclusion of H3K4 methylation en-
sure gene silencing in somatic nuclei. This epigenetic state
makes somatic nuclei less responsive to the transcription
factors in the oocyte, thus contributing to the difficulty in
reprogramming them to pluripotency.
Pluripotency: Preimplantation to Postimplantation
Following implantation of blastocysts, the pluripotent
epiblast cells exhibit an exceptionally rapid cell cycleC(O’Farrell et al., 2004), and they respond to the signals
from the surrounding extraembryonic tissues. The plurip-
otent primitive ectoderm cells in the ICMundergo changes
and form epiblast cells, which initially retain pluripotency
(Figure 1). These epiblast cells, however, differ transcrip-
tionally from the primitive ectoderm cells. For example,
the pluripotency-associated gene nanog is rapidly down-
regulated in the epiblast, as are stella/PGC7 and Rex1
(Chambers et al., 2003; Payer et al., 2003; Sato et al.,
2002). However, other genes such as Fgf5 and Prce are
upregulated in the epiblast cells. Nevertheless, inmany re-
spects, the epiblast cells are pluripotent and will generate
all of the somatic tissues as well as germ cells. Notably,
just as ES cells are derived from PEct cells, it is possible
to generate pluripotent stem cells mimicking epiblast
cells, which have different characteristics from ES cells
(Rathjen et al., 1999). We anticipate that these pluripotent
stem cells from postimplantation embryos may have a
relatively stable epigenetic state compared to ES cells
derived from the ICM since these cells are formed at the
time when a new and possibly more stable epigenetic
state is being established (see below).
The epigenetic mechanism operating at the interface
between preimplantation and postimplantation develop-
ment is perhaps most relevant to the understanding of
how ES cells are maintained in an undifferentiated state
and how the early stages of their differentiation may be
regulated. This period is particularly sensitive to epige-
netic regulation, perhaps due to the necessity to maintain
pluripotency in the primitive ectoderm and subsequently
in the epiblast cells in preparation for their differentiation
into specific cell types, while preventing them from differ-
entiating into extraembryonic lineages such as the tro-
phectoderm cells. It is noteworthy that development up
to the blastocyst stage, which involves cleavage divisions
and is partly regulated by maternally inherited transcrip-
tional and epigenetic modifiers, is relatively less prone to
perturbation. By contrast, the transition to the postimplan-
tation development is driven by epigenetic and genetic
regulators, which are transcribed by the embryo itself.
Thus, whereas preimplantation development primarily
involves both erasure and maintenance of epigenetic
modifications, postimplantation development primarily in-
volves establishment of new epigenetic modifications. In
light of these observations, it is not surprising that some
of the key histone methyltransferases, such as Ezh2,
Eset, G9a, and members of the NuRD complex, have their
critical effects on development during the transition from
pre- to postimplantation development. For example,
oocytes depleted of all maternally inherited Ezh2 can
develop as parthenogenetic blastocysts, but Ezh2 null
blastocysts cannot develop much further following im-
plantation (Erhardt et al., 2003). The significance of
some key epigenetic modifiers on early development is
summarized in Table 1.
In summary, in the zygote at the initiation of develop-
ment, the primary events are centered around the creation
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embryonic transcriptional program. The transition from
the totipotent zygote to the development of pluripotent
PEct cells is one of the key outcomes of early develop-
ment. Transcription factors including Oct4, Sox2, Nanog,
and Cdx2 are important for this development to the
blastocyst stage. By contrast, a common feature during
postimplantation development is the influence of diverse
repressive mechanisms involving histone methyltrans-
ferases, transcription repressors, miRNAs, and Dnmts,
which regulate the transition from PEct to epiblast cells.
Their role may be not simply to sustain pluripotency in
postimplantation epiblasts when nanog, stella/PGC7,
and other similar genes are downregulated but also to pre-
vent premature ectopic expression of lineage-specific
genes. Considering all of the data mentioned above, early
development requires a critical balance between the ac-
tivities of transcriptional and epigenetic factors.
Germ Cells versus Soma
Germ cell lineage generates the totipotent state and pro-
vides the enduring link between all generations. Extensive
epigenetic modifications occur in this lineage, which is
crucial for the development of gametes and totipotency.
Unlike somatic cells, germ cells show expression of
some key pluripotency-specific genes, although they are
highly specialized cells and cannot contribute to chimeras
if introduced into blastocysts. Nevertheless, it is possible
to derive pluripotent stem cells (EG cells) directly from
early PGCs (Matsui et al., 1992; Resnick et al., 1992). No-
tably, germ cells have distinct characteristics that differ
from both epiblast and somatic cells. Specification of
germ cells generally occurs in very early embryos, but in
mice, this event is deferred until postimplantation devel-
opment. PGCs originate from a few pluripotent proximal
epiblast cells, while the remaining cells acquire a somatic
fate. These proximal epiblast cells acquire competence to
form germ cells and show expression of fragilis at E6.25
(Saitou et al., 2002). Evidently, all competent cells are
initially destined toward a somatic fate as judged by the
initiation of the expression of genes such as Hoxb1. How-
ever, cells that undergo specification into PGCs exhibit re-
pression of the somatic program and subsequently show
expression of some of the key pluripotency-specific genes
(Ohinata et al., 2005; Surani et al., 2004; Yabuta et al.,
2006).
Repression of the somatic program during germ cell
specification is observed in many model organisms, al-
though the molecular mechanisms are not conserved
among different species. In C. elegans, repression of the
somatic transcriptional program is achieved throughPie-1,
an RNA-binding protein that interferes with elongation
and/or RNA processing in the P blastomere precursor of
germ cells (Mello et al., 1996; Seydoux and Dunn, 1997).
Taking into account the high levels of H3K4me2 and low
levels of phosphorylation of the RNA polymerase II (Scha-
ner et al., 2003; Seydoux and Dunn, 1997), it seems that,
although the epigenetic status is permissive for gene ex-
pression, the repression machinery extinguishes mRNAs754 Cell 128, 747–762, February 23, 2007 ª2007 Elsevier Inc.by both transcriptional and posttranscriptional mecha-
nisms. In Drosophila, neither H3K4 methylation nor phos-
phorylation of the RNA polymerase II is observed in germ
cell precursors, the pole cells. This transcriptional quies-
cence is instead dependent upon the polar granule com-
ponent (Pgc). In pgc mutant pole cells, H3K4 methylation
and phosphorylation of the RNA polymerase II are ele-
vated, and, more specifically, a variety of genes are ectop-
ically expressed (Deshpande et al., 2004; Martinho et al.,
2004; Nakamura et al., 1996). Thus, in Drosophila, global
repressive histone modifications contribute to the quies-
cence in the germ cells.
In mice, the proximal pluripotent epiblast cells from
which PGCs arise are transcriptionally active. These cells
respond to signals from the extraembryonic tissues and
can undergo differentiation to form either germ cells or
somatic cells (Surani et al., 2004). Therefore, in cells that
are destined to form germ cells, there is a need to impose
repression of the somatic program and ensure that they
retain or reacquire the pluripotent character, which is the
background against which subsequent critical epigenetic
modifications occur in early germ cells. Recent studies
have shown that the transcriptional repressor Blimp1 is
the crucial molecular determinant of the germ cell lineage
in mice (Ohinata et al., 2005; Vincent et al., 2005).
Blimp1: Repression of the Somatic Program
during PGC Specification
Analyses of candidate genes in founder PGCs and
somatic neighbors showed that Blimp1 (or Prdm1) is ex-
pressed in the founder PGCs but not in the somatic neigh-
bors (see Figure 3). Blimp1 is a transcriptional repressor
with an N-terminal PR/SET domain, a proline-rich region,
five C2H2 zinc fingers, and a C-terminal acidic domain.
Blimp1 was first identified as the key gene involved in
the specification of plasma cells from B cells, partly
through its repression of the B cell-specific genetic pro-
gram. It is noteworthy that Blimp1 expression is detected
in many tissues and in many organisms. A variety of func-
tions are attributed to Blimp1 protein, but it seems that it is
only inmice (and perhaps othermammals) that it has a role
in germ specification. The diverse roles of this highly con-
served gene suggest that it must have acquired new en-
hancers or regulatory elements for its role in germ cell
specification in mammals.
Blimp1 is first detected in about six cells among the
proximal pluripotent epiblast cells at E6.25 of develop-
ment, prior to the onset of gastrulation (Ohinata et al.,
2005). This number increases progressively to approxi-
mately 28 cells by the late streak stage and approximately
40 specified PGCs at E7.25 of development. Genetic line-
age tracing experiments confirmed that all the early
Blimp1-positive cells are lineage-restricted PGC precur-
sor cells (Ohinata et al., 2005). Deletion of Blimp1 results
in aberrant development of founder PGCs as they cease
proliferation and form a tight cluster, unlike in normal em-
bryos, where they begin to migrate away from the cluster.
More significantly, these mutant cells show inconsistent
repression of the somatic program as judged by the
Figure 3. Epigenetic Regulation of Germ
Cell Specification
Primordial germ cells (PGCs) are specified from
pluripotent epiblast cells. The Blimp1/Prmt5
complex potentially represses the somatic pro-
gram during specification and subsequently
maintains this lineage. A number of key epige-
netic modifications (for example, an increase in
H3K27me3 and loss of H3K9me2) that are
consistent with pluripotency are observed, to-
gether with the re-expression of pluripotency-
specific genes such as nanog. More extensive
erasure of epigenetic modifications follows at
E11.5 in PGCs in the developing gonads
when Blimp1/Prmt5 exits from the nucleus.aberrant expression ofHoxb1. The mutant cells also fail to
show expression of stella as well as Sox2 consistently, the
latter being a key gene that is associated with pluripo-
tency. Recently, Prdm14, another member of the PRDM
family, has been detected very early and specifically in
PGC precursors, which suggests that this factor may
also have a role in PGC specification (Yabuta et al., 2006).
The Blimp1/Prmt5 Complex in the Germ Cell Lineage
Blimp1 has the potential to form many different types of
repressive complexes. For example, it apparently forms
a complex with a histone modifier, G9a, as well as with
Groucho and Hdac2, and other complexes may also
form in a context-dependent manner. Recent studies
have indicated that Blimp1 can form a novel complex
with Prmt5, an arginine-specific histone methyltransfer-
ase, which mediates symmetrical dimethylation of argi-
nine 3 on histone H2A and/or H4 tails (H2A/H4R3me2s)
(Ancelin et al., 2006). Blimp1 and Prmt5 are coexpressed
in the mouse germ cell lineage, and this is associated
with high levels of the H2A/H4R3me2s modification in
germ cells. It is important to note that Prmt5 also has the
potential to methylate other protein substrates outside
the nucleus, such as spliceosomal Sm proteins. Interest-
ingly, in flies, mutation in the Prmt5 homolog, Capsuleen/
dart5, has a striking effect on germ cells. The males are
sterile, as the Capsuleen/dart5 mutation affects develop-
ment of spermatocytes, whereas in females, Capsuleen/
dart5mutation affects specification of germ cells (Gonsal-
vez et al., 2006; Anne et al., 2007). In mice, the presence of
Prmt5 in the nucleus of PGCs may be critical through its
role in histone H2A/H4R3me2s modification at the earliest
stages of the formation of PGC precursors and germ cell
specification, but its precise role is currently under inves-
tigation (W.W. Tee, personal communication). Never-
theless, a number of putative targets have been identified
for the Blimp1/Prmt5 complex in the nucleus, amongwhich is Dhx38, an RNA helicase whose homolog has
a role also in the C. elegans germline. In the mouse
PGCs, Dhx38 is repressed until E12.5, and this repression
is associated with H2A/H4R3me2s modification of the lo-
cus. It is likely that the Blimp1/Prmt5 complex has a con-
tinuing role in the mouse germ cell lineage as a repressive
complex with many other targets. One of the potential
roles of this complex may also be to maintain the early
germ cell lineage at a time when the epigenetic status of
early PGCs is relatively plastic and they show expression
of some key genes that are detected generally in pluripo-
tent cells (see below).
Epigenetic Modifications and Lineage-Specific
Character of Founder PGCs
A key feature of the specification of the germ cell lineage is
that it reacquires and retains some of the essential charac-
teristics of pluripotency (Figure 3). Some of the initial epi-
genetic changes in the founder PGCs are probably neces-
sary for this generation of a unique pluripotent-like state,
which is rapidly lost from the majority of the cells that dif-
ferentiate into somatic cells.
Shortly after specification, a genome-wide change in
histone modifications occurs in newly specified PGCs.
There is loss of H3K9me2 in the PGCs, while the
H3K27me3 mark becomes more prominent (Seki et al.,
2005; K. Ancelin, P.H., and M.A.S., unpublished data). It
has been observed that early PGCs downregulate
Ehmt1 (Glp) after E7.25, which is not observed in the
neighboring somatic cells (Yabuta et al., 2006). By con-
trast, expression of Ehmt2 (G9a) remains unchanged in
both somatic cells and PGCs. It is known that G9a and
GLP form a complex that is essential for H3K9me2 meth-
ylation (Tachibana et al., 2005), indicating that the down-
regulation of Glp may allow loss of H3K9me2 to proceed
in PGCs. Thus, while mutation in G9a is early embryonic
lethal, this does not affect PGC specification (K. Ancelin,Cell 128, 747–762, February 23, 2007 ª2007 Elsevier Inc. 755
P.H., andM.A.S., unpublished data). Alternatively, the era-
sure of H3K9me2may also involve a histone demethylase,
such as Lsd1, or possibly other mechanisms. At the same
time, the elevation of H3K27me3 is associated with high
expression of Ezh2 in PGCs, which may be a key charac-
teristic of pluripotency since many somatic genes are re-
pressed by H3K27me3 in pluripotent stem cells (Bernstein
et al., 2006; Boyer et al., 2006b). It will be important to
determine whether a similar mechanism also contributes
to the repression of somatic genes in PGCs. In addition,
Dnmt3b is downregulated specifically in PGCs after
E7.25, and, while observed later in PGCs, the Dnmt3b pro-
tein is located in the cytoplasm (Hajkova et al., 2002). This
may allow DNA demethylation to proceed once PGCs
enter the gonads (see below). It will be important to inves-
tigate the interactions between diverse epigenetic factors
to clarify which factors regulate the epigenetic status of
specific genomic targets in germ cells, such as the
gene-encoding regions, repetitive elements, and imprint-
ing control elements (see Figure 3).
As the germ cells increase in number, they start to
migrate into the developing gonads, which they reach
around E10.5. Soon afterwards, PGCs undergo a wave
of genome-wide DNA demethylation, which is accompa-
nied also by the profound changes in chromatin configura-
tion and erasure of some histone modification marks
(P.H., K. Ancelin, and M.A.S., unpublished data). This
DNA demethylation affects single-copy genes as well as
genomic imprints and repetitive elements, and the kinetics
of this epigenetic event is indicative of an active process.
The female PGCs, which initially show random X chromo-
some inactivation as seen in somatic cells, subsequently
show reactivation of the Xi, most likely as a part of the
global epigenetic reprogramming process.
Evidence suggests that the entry of PGCs into the gen-
ital ridge may be important for the onset of the reprogram-
ming process (Tam et al., 1994). It is possible that signal-
ing molecules from these somatic cells may regulate this
major epigenetic event, which bears some similarity to
the epigenetic reprogramming event in the ICM of blasto-
cysts discussed above, and the importance of the appro-
priate developmental niche. There is reactivation of the
X chromosome and transient loss of Polycomb chromatin
marks in both instances. However, while the erasure of
chromatin modifications in the ICM is perhaps important
for generating pluripotency, the extensive erasure of epi-
genetic modifications in the gonadal PGCs is an important
step toward the eventual regeneration of totipotency. In
both cases, such extensive epigenetic modifications are
a route to significantly alter the phenotypic and develop-
mental state of cells. PGCs also show similarity to the
events in the zygote, including extensive erasure of DNA
methylation, which allows the transition from the zygotic
to the embryonic developmental program. It seems that
the PGCs may employ a combination of epigenetic mech-
anisms and the expression of key molecules that are seen
in both the zygote and the ICM. This combination of the
epigenetic mechanisms enabling erasure of both DNA756 Cell 128, 747–762, February 23, 2007 ª2007 Elsevier Inc.methylation and histonemodificationsmakes the germline
a unique epigenetic entity.
The epigenetic modifications that occur at the estab-
lishment of the germ cell lineage discussed above are
accompanied by the expression of some of the key pluri-
potency-associated genes, such as Sox2, which pre-
cedes expression of stella, a marker of specified founder
PGCs. Also, nanog, which is downregulated in the epiblast
immediately after implantation of the embryo, shows in-
creased transcription in founder PGCs, and the protein
is detected shortly thereafter (Yamaguchi et al., 2005).
Oct4, on the other hand, is continually expressed through-
out in PGCprecursors and following their specification on-
ward. Thus, the three key pluripotency-associated genes,
Oct4, Sox2, and nanog, are detected in the early PGCs.
However, other markers of pluripotency are detected later
in the germ cell lineage. For example, Esg1 is not detected
until E8.5, while Dppa2 and Dppa4 are not detected until
E10.5 or slightly later. Therefore, PGCs have their own
specific characteristics with respect to the expression of
pluripotency-specific genes.
While the PGCs exhibit expression of some pluri-
potency-specific genes, there is also the expression of
lineage-specific genes. Among these is fragilis. In addi-
tion, there is the expression of Nanos3, a mouse homolog
of an RNA-binding protein that is essential for the develop-
ment of PGCs following their specification. Dnd, which
has a role in RNA metabolism, is also detected in slightly
more advanced PGCs. Expression of other genes such
as themouse homologs of vasa (mvh) andDazl is detected
later with the entry of PGCs into the developing gonads.
Expression of these genes emphasizes that PGCs have
unique lineage-specific characteristics, which coexist
with the expression of pluripotency-specific genes.
Genetic/Epigenetic Regulation of Pluripotent
Stem Cells
As discussed above, the pluripotent PEct cells of the ICM
and the early PGCs can both give rise to pluripotent stem
cells (ES and EG cells, respectively) in culture. Once
established, the pluripotent ES and EGcells can, albeit un-
der strict culture conditions, perpetuate their undifferenti-
ated pluripotent state indefinitely. The ES and EG cells are
thus in vitro derivatives without strict counterparts in vivo.
From ICM to Pluripotent ES Cells
Currently, little is known about how pluripotent PEct cells
in the ICM are transformed into pluripotent ES cells or
about potential involvement of any epigenetic regulators
in this process. However, it is likely that in the blastocyst,
the PEct cells may have already undergone the crucial
stages of epigenetic reprogramming, including the era-
sure of epigenetic modifications associated with the
Xi chromosome and possibly even the overall derepres-
sion of the genome within the ICM niche as described
above. The pluripotent ES cells thus seem to capture a
state that may occur only transiently in vivo, since the
PEct cells progress rapidly through development to form
the epiblast cells.
The derivation of mouse ES cells is usually carried out in
the presence of LIF and FCS or BMP4 (Ying et al., 2003).
These conditions must allow for the selection of cells
that ultimately form the pluripotent ES cells. One of the ef-
fects of LIF is to induce Stat3 phosphorylation that has the
potential to activate transcription of target genes. How-
ever, the derivation of human ES cells, which are similar
but not identical to mouse ES cells, requires the presence
of Fgf2. The reason for the differences between these
stem cells is unclear. Detailed analysis of transcription
and epigenetic regulation of ES cells gives further insights
into the nature of the pluripotent state. The transcription
factors Oct4, Nanog, and Sox2, which are present in the
ICM, are critical for maintaining pluripotency of stem cells.
The interaction between Oct4 and Cdx2, which is central
to cell fate decision between ICM and trophectoderm, is
also evident since induced expression of Cdx2 in ES cells
causes their differentiation into trophectoderm cells (Niwa
et al., 2005). It is likely that Cdx2 is normally repressed in
mouse ES cells by an unknown epigenetic mechanism
since they are highly refractory to differentiation into extra-
embryonic tissues. The role of Nanog in this context is to
prevent the ES cells from acquiring the PEnd fate, which
can be overcome by expression of Gata4 and Gata6 in
ES cells. These two genes are normally repressed in ES
cells (Chazaud et al., 2006).
Although pluripotent mouse ES cells seldom differ-
entiate into extraembryonic tissues, they are poised to dif-
ferentiate into all of the somatic cells found in the embryo
itself. The genome-wide analysis of the key transcription
factors Oct4, Sox2, and Nanog and some of the epige-
netic regulators implicated in the plasticity of ES cells
has been reported recently (Boyer et al., 2006a; Loh
et al., 2006). These factors have a large number of targets
that are both transcriptionally active and repressed, al-
though the comparisons between the targets in mouse
and human show only a slight overlap. The reasons for
this are unclear, but it could be due to real differences be-
tween mouse and human ES cells or a reflection of differ-
ences in technical approaches between the two studies.
In the human ES cells, the factors were associated with
many genes needed for development of both extraembry-
onic and embryonic tissues, suggesting their direct role in
regulating pluripotency. In both types of ES cells, genes
encoding for some of the histone modifiers such as Jarid2
and Smarcad1 as well as Rif1 were detected (Boyer et al.,
2006a). Some targets such as Esrrb were found to be tar-
gets only in mouse ES cells.
The pluripotency of ES cells is underpinned by an un-
usual state of their chromatin. Recent studies have dem-
onstrated that ES cell chromatin is in a highly dynamic
state, with an apparently transient association of chroma-
tin structural proteins, which is reflected in the relatively
decondensed chromatin of ES cells (see the Review by
T. Misteli, page 787 of this issue). This distinct state of
chromatin in ES cells is complemented by a unique
epigenetic mechanism to sustain pluripotency. A large
number of genes that are important for developmenthave the H3K27me3 repressive mark, which is imposed
by Ezh2. However, at the same time, these sites also
have the H3K4me3 mark, which is associated with active
genes (Bernstein et al., 2006; Boyer et al., 2006b; see also
the Reviews by B. Li et al. and B.E. Bernstein et al., pages
707 and 669 of this issue). The presence of these dual and
opposing epigenetic marks on certain genes suggests
that they are poised to be released from repression as
soon as the ES cells start to undergo differentiation. These
dual marks are also associated with the highly conserved
noncoding elements, suggesting evolutionary conserva-
tion of these DNA regions. More importantly, many of
the sites with these epigenetic marks are also bound by
Oct4, Sox2, and Nanog, the key factors associated with
pluripotency. The target loci of these transcription factors
associated with the repressive chromatin mark also repli-
cate early in S phase in ES cells (Azuara et al., 2006), which
also suggests that, in pluripotent stem cells, these loci are
poised to be activated. Consistently, two members of the
PRC2 complex, Eed andSuz12, are also detected at these
loci and may be responsible for repression of these target
genes, a repression that is apparently relieved in Eedmu-
tant ES cells (Boyer et al., 2006b; Loh et al., 2006).
Mutations in several key epigenetic regulators, includ-
ing Ezh2, Eset, MBD3, and Dicer, abolish the ability to
generate pluripotent ES cells from the ICM (see Table 1).
Notably, however, some of these proteins, such as
Mbd3 and Dicer, can be deleted after the ES cells are es-
tablished, suggesting that different sets of molecular fac-
tors are necessary for the derivation and maintenance of
the pluripotent state. It should be noted, however, that in
both cases, the mutant ES cells are defective in their po-
tential to undergo differentiation into diverse cell types,
which shows that their pluripotency is indeed affected.
From PGCs to Pluripotent EG Cells
PGCs exhibit lineage-specific characteristics as well as
many characteristics similar to pluripotent cells. Impor-
tantly, it is also possible to generate pluripotent stem cells
(EG cells) from PGCs starting from approximately E8.5,
which coincides with epigenetic modifications following
PGC specification and the expression of some key pluri-
potency-specific genes (Durcova-Hills et al., 2006). The
derivation of EG cells from PGCs is possible until about
E11.5, when the extensive epigenetic reprogramming of
the genome occurs, followed by progressive downregula-
tion of some pluripotency-specific genes. The precise
mechanism involved in PGC-to-EG dedifferentiation is
as yet unknown, except that the presence of Fgf2 as
well as LIF and stem cell factor (SCF) is needed for this
transformation. In vivo, PGCs can also undergo transfor-
mation into teratocarcinoma cells, and pluripotent EC
cells can be derived from them. A number of mutations
are known to accelerate this process, including those in
Dnd, Pten, and Pgct1, among others.
The potential to derive EG cells from PGCs at E8.5–
E11.5 coincides with the presence of a specific chromatin
signature, including enrichment of H3K27me3 and
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M.A.S., unpublished data), which may be required for ob-
taining pluripotency during the derivation of EG cells. It is
similarly striking that both PEct cells of the ICM and PGCs
possess the ability to dramatically alter their chromatin,
which suggests that this feature may be important for their
ability to give rise to pluripotent stem cells. It is also partic-
ularly noteworthy that during the derivation of EG cells
from PGCs, there is extensive epigenetic reprogramming
of the genome as seen in the gonadal PGCs described
above (Tada et al., 1998), including extensive DNA deme-
thylation and the erasure of the parental imprints, even
when EG cells are derived from E8.5 PGCs. In vivo, this
event is timed to occur only when the PGCs enter into
the genital ridges. EG cells are in most respects very sim-
ilar to ES cells, except for the erasure of the epigenetic
modifications associated with genomic imprints.
It is most likely that Blimp1 is downregulated during the
derivation of EG cells from PGCs, since Blimp1 protein is
not detectable in EG cells, or indeed in any other type of
pluripotent stem cells. This downregulation of Blimp1
may cause phenotypic changes in the germ cell lineage.
It is likely that during the EG cell derivation, a number of
targets of the Blimp1/Prmt5 complex are derepressed,
such as Dhx38 (Ancelin et al., 2006). Ectopic expression
of Blimp1 in pluripotent EC cells leads again to the repres-
sion of Dhx38. It will be of interest to determine whether
EC cells and indeed all pluripotent stem cells acquire
a PGC character upon expression of Blimp1.
Reprogramming and Rederived Pluripotency
In principle, any adult cell can be reprogrammed to reac-
quire pluripotency, albeit at a very low frequency. For an
optimum response, reprogramming of somatic cells re-
quires erasure of the existing epigenetic modifications
and reinitiation of a pluripotency-specific transcriptional
network in the reprogrammed cells. Much of the evidence
for this comes from nuclear transplantation into oocytes.
Additionally, pluripotent stem cells themselves also have
the potential to reprogram somatic cells in ES/EG-somatic
cell hybrids (Tada et al., 1997, 2001).
The mechanism that confers pluripotency on somatic
nuclei in ES/EG-somatic cell hybrids has yet to be fully in-
vestigated. It is possible that ES cells, which have the key
transcription factors necessary for pluripotency, also have
the potential to erase some of the histone modifications
from somatic nuclei in ES-somatic hybrids, a property
likely to be inherited from the PEct cells of the ICM. Simi-
larly, somatic nuclei in EG-somatic hybrids also acquire
characteristics of pluripotency. However, in the latter
there is also extensive erasure of genomic imprints and
DNA demethylation, which is not observed in ES-somatic
cell hybrids (Tada et al., 1997, 2001). EG cells must
acquire this additional property from PGCs. Somatic cells
hybridized with ES cells exhibit dramatic changes in
histone modifications, which include enrichment of
H3K4me2/3 and H3K27me3 in gene loci that are normally
repressed in ES cells, while gene loci that are normally
expressed in ES cells are reset predominantly with an758 Cell 128, 747–762, February 23, 2007 ª2007 Elsevier Inc.H3K4me3 epigenetic mark (Kimura et al., 2004). Thus,
the overall epigenetic status of the somatic nucleus is re-
set to resemble the ES cell state. Similarly, the inactive
X chromosome in the somatic nucleus is reactivated in hy-
brid cells (Tada et al., 2001). Recent studies have also
shown that the frequency of reprogramming of somatic
nuclei in hybrids with ES cells is significantly enhanced, ei-
ther directly or indirectly, following increased expression
of Nanog in ES cells (Silva et al., 2006). However, it is
known that remodeling of the somatic nucleus can occur
in the absence of Nanog, as seen with somatic nuclei
transplanted into oocytes.
Recent studies have shown that somatic cells can be
rendered pluripotent and made to resemble ES cells by
the introduction of four transcription factors, Oct4, Sox2,
Klf4, and c-Myc, albeit at a very low frequency (Takahashi
and Yamanaka, 2006). The first two are the core transcrip-
tion factors of pluripotency, while Klf4 and c-Myc are in-
volved in self-renewal of ES cells. Klf4 can also augment
the levels of Oct4 and is implicated in transactivation of
lefty (Nakatake et al., 2006). The detection of endogenous
nanog expression in these reprogrammed cells probably
follows activation by Oct4 and Sox2. Thus, the four factors
may alter the existing transcriptional network quite exten-
sively since the reprogrammed cells show both the capac-
ity for self-renewal and extensive differentiation in chime-
ric fetuses, but their contribution to the germline needs
further investigation. A detailed microarray analysis of
these pluripotent cells shows that their gene expression
pattern is similar but not identical to normal ES cells.
Some of the key genes, including Sox2 and Oct4, are
not expressed from the endogenous copies to the extent
seen in normal ES cells, and these cells must thus rely
on the constitutive expression of introduced transgenes.
Following transplantation into the oocyte, somatic nu-
clei undergo epigenetic modifications, as exemplified by
the initial increase in the size of the nucleus indicating an
alteration of the chromatin template, while being exposed
to the maternally inherited transcription factors. More im-
portantly, ES cells derived from the resulting blastocysts
are almost identical to the ES cells derived from normal
embryos (Brambrink et al., 2006). Their transcriptional
profile and developmental potential are indistinguishable
from normal ES cells, probably because the donor so-
matic nucleus was exposed to the appropriate epigenetic
modifications in the oocyte and subsequently in the ICM.
Transcription factors acting on such epigenetically modi-
fied nuclei during development may allow almost com-
plete reprogramming of somatic nuclei to pluripotency,
albeit at a low frequency. By contrast, ES cells generated
in vitro from somatic cells by the introduction of transcrip-
tion factors alone as described above (Takahashi and
Yamanaka, 2006) are similar but not identical to the nor-
mal ES cells with only partial epigenetic reprogramming
as judged by the methylated status of Oct4 in these cells.
These studies suggest that a combination of epigenetic
and genetic programs acting in concert is necessary for
successful induction of complete pluripotency. However,
it is important to bear in mind that the environmental fac-
tors and signaling molecules may also have a significant
role in effective reprogramming.
Perspective
The transition from the totipotent zygote leading to the
establishment of pluripotent PEct cells within the ICM
involves an interaction between genetic and epigenetic
modulators. The early blastomeres rely more on intrinsic
regulators, including maternal factors that drive largely
stereotypical responses. The cessation of cleavage divi-
sions and the resumption of normal cell divisions are prob-
ably accompanied by epigenetic reprogramming events in
PEct cells in the ICM, including X reactivation and possible
general derepression of the epigenome, as these cells ac-
quire plasticity and responsiveness to extrinsic signals.
The early totipotent blastomeres have no capacity for
self-renewal, which is a property acquired later by the plu-
ripotent cells within the ICM. The concomitant responsive-
ness to extrinsic signals acquired by these cells makes it
possible to derive self-renewing pluripotent ES cells
in vitro. These cells exhibit a unique epigenetic state that
ensures their ability to differentiate into somatic cells and
germ cells, except that differentiation into extraembryonic
tissues is largely repressed.
Pluripotency is also initially maintained in early postim-
plantation epiblast cells, which undergo very rapid cell
divisions. At this stage, many epigenetic modifiers and re-
pressors are used to ensure rigorous control over differen-
tiation into diverse cell types. Germ cell specification,
which involves repression of the somatic program as the
cells acquire characteristics that are associated with plu-
ripotency, also occurs at this time. These early germ cells
can in turn be used to generate pluripotent stem cells.
Subsequently, there is extensive epigenetic reprogram-
ming of the genome, notably the extensive erasure of
the epigenetic modifications that are essential for even-
tually generating totipotency. Knowledge gained from
development of the pluripotent state in vivo involving an
interaction between the transcriptional network and epi-
genetic mechanisms may provide important insights that
will aid in generating pluripotent cells directly from any
somatic cell.
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